2015 annual financial data

Galectin Therapeutics 2015 Operating margin

Galectin Therapeutics 2015 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was -20,079,000 USD and net income was -20,027,000 USD.
Operating cash flow was -16,983,000 USD.

Get free Galectin Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-20,079,000 USD
Net income
-20,027,000 USD
Operating cash flow
-16,983,000 USD